| abstract |
Corticosteroid particles preparation is provided for treating pain, including as the pain caused by inflammatory disease such as osteoarthritis or rheumatoid arthritis, and for slowing down, preventing or reverse as the institutional framework damage caused by inflammatory disease, such as the joint caused by osteoarthritis or rheumatoid arthritis and/or periarticular tissue damage.With slow release formulation（With or without immediate-release component）Local administration corticosteroid particles preparation, the slow release formulation is while effect is produced to endogenous cortisol production with clinically non-limiting influence or without measurable influence. |